Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment

Background: Cognitive impairment is prevalent in Parkinson's disease (PD), affecting 15–20% of patients at diagnosis. α-synuclein expression and genetic polymorphisms of Apolipoprotein E (ApoE) have been associated with the presence of cognitive impairment in PD although data have been inconsis...

Descripción completa

Detalles Bibliográficos
Autores principales: Samat, Nor A., Abdul Murad, Nor A., Mohamad, Khairiyah, Abdul Razak, Mohd R., Mohamed Ibrahim, Norlinah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742342/
https://www.ncbi.nlm.nih.gov/pubmed/29326545
http://dx.doi.org/10.3389/fnins.2017.00712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742342/
https://www.ncbi.nlm.nih.gov/pubmed/29326545
http://dx.doi.org/10.3389/fnins.2017.00712

Ejemplares similares